Sugar and fat – that's where it's at: metabolic changes in tumors
Open Access
- 20 February 2008
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research
- Vol. 10 (1) , 202
Abstract
Tumor cells exhibit an altered metabolism, characterized by increased glucose uptake and elevated glycolysis, which was first recognized by Otto Warburg 70 years ago. Warburg originally hypothesized that these metabolic changes reflected damage to mitochondrial oxidative phosphorylation. Although hypoxia and hypoxia inducible factor can induce transcriptional changes that stimulate glucose transport and glycolysis, it is clear that these changes can occur in cultured tumor or transformed cells cultured under normoxic conditions, and thus there must be genetic alterations independent of hypoxia that can stimulate aerobic glycolysis. In recent years it has become clear that loss of p53 and activation of Akt can induce all or part of the metabolic changes reflected in the Warburg effect. Likewise, changes in expression of lactate dehydrogenase and other glycolytic control enzymes can contribute to increased or altered glycolysis. It is also clear that changes in lipid biosynthesis occur in tumor cells to support increased membrane biosynthesis and perhaps the altered energy needs of the cells. Changes in fatty acid synthase, Spot 14, Akt, and DecR1 (2,4-dienoylcoenzyme A reductase) may underlie altered lipid metabolism in tumor cells and contribute to the ability of tumor cells to proliferate or metastasize. Although these advances provide new therapeutic targets that merit exploration, there remain critical questions to be explored at the mechanistic level; this work may yield insights into tumor cell biology and identify additional therapeutic targets.Keywords
This publication has 69 references indexed in Scilit:
- Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor DevelopmentMolecular and Cellular Biology, 2007
- HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and ProliferationCancer Cell, 2007
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Hypoxia-Inducible Factors, Stem Cells, and CancerCell, 2007
- The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysisGenes & Development, 2007
- Hypoxia-inducible factors: central regulators of the tumor phenotypeCurrent Opinion in Genetics & Development, 2007
- Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanismJournal of Cell Biology, 2006
- Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactationJournal of Lipid Research, 2003
- Haptoglobin-Related Protein (Hpr) Epitopes in Breast Cancer as a Predictor of Recurrence of the DiseaseNew England Journal of Medicine, 1989
- On the Origin of Cancer CellsScience, 1956